Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 819.00
-6.45 (-0.78%)
Oct 1, 2026, 3:30 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 160.25 billion as of October 1, 2026. Its market cap has decreased by -9.55% in one year.
Market Cap
160.25B
Enterprise Value
172.53B
Revenue
77.84B
Ranking
n/a
PE Ratio
23.11
Stock Price
819.00
ChartMarket Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 160.25B, an increase of 1,680.21%. That is a compound annual growth rate of 21.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 160.25B | -3.65% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 371.60B |
| Wockhardt | 355.47B |
| Piramal Pharma | 274.61B |
| Cohance Lifesciences | 173.42B |
| Eris Lifesciences | 169.16B |
| Alivus Life Sciences | 165.15B |
| NATCO Pharma | 148.40B |
| Sudeep Pharma | 128.63B |